Brief: BB Biotech Q2 Net Loss of CHF 233 Million
22/07/2022 06:26
July 22 (Reuters) - BB BIOTECH AG BION.S :
* Q2 SHARES TOTAL RETURN DOWN 12.5% IN CHF AND DOWN 10.9% IN
EUR
* Q2 NET LOSS OF CHF 233 MILLION
* OUTLOOK 2022: BB BIOTECH EXPECTS DEALS IN BIOTECH SECTOR
TO PICK
UP DURING SECOND HALF OF YEAR
Source text for Eikon: ID:nEQ5FyzGna
Further company coverage: BION.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM